Alteryx Inc (NYSE:AYX) CFO Kevin Rubin sold 13,000 shares of the stock in a transaction that occurred on Wednesday, July 10th. The stock was sold at an average price of $117.98, for a total transaction of $1,533,740.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Kevin Rubin also recently made the following trade(s):
- On Monday, June 10th, Kevin Rubin sold 13,000 shares of Alteryx stock. The stock was sold at an average price of $99.46, for a total transaction of $1,292,980.00.
- On Thursday, May 23rd, Kevin Rubin sold 10,000 shares of Alteryx stock. The stock was sold at an average price of $89.20, for a total transaction of $892,000.00.
Shares of NYSE:AYX opened at $115.00 on Friday. The company has a market cap of $7.16 billion, a P/E ratio of -575.00, a price-to-earnings-growth ratio of 49.69 and a beta of 1.24. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.58 and a current ratio of 1.58. The company has a 50 day moving average of $101.98. Alteryx Inc has a one year low of $38.58 and a one year high of $119.26.
Several analysts recently issued reports on AYX shares. JMP Securities increased their price target on shares of Qualys from $85.00 to $100.00 and gave the stock a “market outperform” rating in a research report on Thursday, May 2nd. DA Davidson increased their price target on shares of Alteryx to $95.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 12th. Wedbush reiterated a “buy” rating on shares of Liquidia Technologies in a research report on Thursday, May 2nd. Oppenheimer increased their price target on shares of Alteryx from $93.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, June 17th. Finally, Goldman Sachs Group started coverage on shares of HubSpot in a research report on Friday, June 7th. They set a “buy” rating and a $223.00 price target on the stock. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $102.97.
Large investors have recently modified their holdings of the stock. Cooper Haims Advisors LLC bought a new position in Alteryx in the 1st quarter valued at approximately $509,000. Assenagon Asset Management S.A. bought a new position in shares of Alteryx during the first quarter valued at $4,976,000. Legal & General Group Plc raised its stake in shares of Alteryx by 3.4% during the fourth quarter. Legal & General Group Plc now owns 4,541 shares of the company’s stock valued at $270,000 after acquiring an additional 149 shares during the last quarter. Marshall Wace LLP bought a new position in shares of Alteryx during the first quarter valued at $6,222,000. Finally, Hamilton Lane Advisors LLC raised its stake in shares of Alteryx by 493.6% during the first quarter. Hamilton Lane Advisors LLC now owns 79,777 shares of the company’s stock valued at $6,691,000 after acquiring an additional 66,337 shares during the last quarter. 64.24% of the stock is owned by institutional investors and hedge funds.
Alteryx Company Profile
Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, and citizen data scientists worldwide. Its software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.
Further Reading: What is an overbought condition?
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.